Abbott Ties Up With Biocon Unit To Develop Nutrition Products In India

Date : 05/03/2012 @ 1:09AM
Source : Dow Jones News
Stock : Abbott Laboratories (ABT)
Quote : 44.59  0.64 (1.46%) @ 12:32PM

Abbott Ties Up With Biocon Unit To Develop Nutrition Products In India

Abbott labs (NYSE:ABT)
Historical Stock Chart

5 Years : From May 2012 to May 2017

Click Here for more Abbott labs Charts.

U.S. drug maker Abbott Laboratories (ABT) has tied up with a unit of Indian biotechnology company Biocon Ltd. (532523.BY) to set up a research and development center for nutrition products.

Abbott will set up the center in India in collaboration with Biocon's contract research unit, Syngene. More than 50 researchers and scientists will be based at the center, which is expected to open in June, the companies said in a joint statement Thursday.

Syngene currently has a research tie-up with Bristol-Myers Squibb Co., under which it provides research and development services for the company's discovery and early drug development processes.

-By Rumman Ahmed, Dow Jones Newswires; 91-9845104173; rumman.ahmed@dowjones.com

Latest ABT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.